CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Looking for ways to make immediate money? Discover effective strategies that can help you earn fast and address your financial needs.
16,488 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Bitcoin trades near $63,000 as pardon discussions around Sam Bankman-Fried surface in crypto news. A $32 million hack...
Insider moves can spark questions about a stock's future. This guide breaks down what insw sold discretionary shares ...
Two Roundhill ETFs harness a 0DTE covered call strategy to deliver regular Friday payouts, but investors should weigh...
Hyliion Holdings stock charged higher today as new analyst coverage and operational milestones sparked optimism. This...
SpaceX is courting attention ahead of a potential Nasdaq debut. Some ETFs offer pre-IPO exposure via SPVs, but the st...
Oracle's latest guidance sparked a sell-off as investors weigh AI-driven capital outlays against cash flow. This arti...
As Switzerland heads to the polls on a population cap, the country’s biotech and food giants warn that limiting immig...
XRP trades near $1.15 as sentiment tumbles to multi-month lows. History shows a similar lull preceded a sharp rebound...
Bitcoin faces a crucial weekend hurdle near $64,000 as ETF inflows rebound and macro momentum shifts. A sustained bre...
Fox agreed to buy Roku for $22 billion, sending Roku stock to four-year highs and triggering debate over how the deal...
Private reverse mortgage products are outpacing HECMs, underscoring a broader push to revive the HECM for Purchase. I...